Drug Trial Radar · NCT06285799
Safety and Effectiveness of Iron Hydroxide Adipate Tartrate (IHAT) in Iron Deficient Premenopausal Women
Last checked: Nov 19, 2026Latest source record: Jun 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
180
Actual
Start
Mar 5, 2024
Primary completion
Feb 11, 2025
Study completion Feb 15, 2025
Sponsor
- Lead sponsor
- Nemysis LtdIndustry
- Sponsor type
- Industry
- Collaborators
- RDC Clinical Pty Ltd
- First posted
- Feb 29, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a double blind, randomised, placebo-controlled trial to evaluate orally-dosed Iron Hydroxide Adipate Tartrate (IHAT) at 2 different dose levels compared to placebo for increasing serum ferritin levels in iron deficient, but otherwise healthy premenopausal women over 12 weeks.
Conditions
- Iron-deficiency
Interventions
Low Dose IHATDrug
Once daily dose of 1 IHAT capsule (100mg IHAT per capsule) and once daily dose of 1 placebo capsule (carob flour)
High Dose IHATDrug
Twice daily dose of 1 IHAT capsule (100mg IHAT per capsule)
Carob FlourDrug
Twice daily dose of 1 placebo capsule (carob flour)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of women recovering from iron deficiency at week 12Time frame: week 12
Locations
1 site in 1 country. Site status is shown where the registry gives one.
RDC Clinical Pty Ltd
Brisbane, Queensland, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.